Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium vs Rivastigmine for HIV-associated Neurocognitive Impairment
NCT01348282Phase 4Completed
- Start
- May 2011
- Primary completion
- Mar 2014
- Modality
- Reversible Covalent Inhibitors, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of lithium, rivastigmine in HIV-associated neurocognitive disorder (HAND). Started May 2011; status: completed.
02
Drugs
lithiumrivastigmine
03
Conditions
HIV-associated neurocognitive disorder (HAND)
Beyond the preview
Go deeper on NCT01348282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348282.